The complaint, which also targets asset manager TPG, focuses on 200,000 recalled devices, according to a Feb. 2 news release from law firm Parker Waichman. Thousands of implants have been recalled in 2021 and 2022, and the most recent instance involved hip devices with failed polyethylene liners, which could have been degraded due to oxygen exposure from nonconforming packaging.
A spokesperson for Exactech told Becker’s in a Feb. 2 email that the company couldn’t provide comment on the complaint.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
